<DOC>
	<DOCNO>NCT02985463</DOCNO>
	<brief_summary>`` Left Atrial Appendage Occlusion Biomarker Evaluation '' ( LABEL ) single-center , prospective observational study evaluate change expression biomarkers eligible patient percutaneous implantation leave atrial appendage ( LAA ) occlusion device mid-term follow-up .</brief_summary>
	<brief_title>Left Atrial Appendage Occlusion Biomarker Evaluation</brief_title>
	<detailed_description>This study evaluate change different type biomarkers successful percutaneous implantation LAA occlusion device . Biomarker evaluation focus blood derive biomarkers include neurohormone , protein , cytokine , microRNAs metabolomics .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>non valvular atrial fibrillation , make anticoagulation prevent embolic stroke LAA contraindication therapy oral anticoagulant : refusal take oral anticoagulation HasBledscore 3 prior bleeding oral anticoagulation 18 year severely reduce left atrial function mechanical heart valve pulmonary embolism deep vein thrombosis myocardial infarction within last 3 month electrical cardioversion within 30 day potential occluder implantation atrial septum defect interventional/surgical occlusion ASD status heart transplant symptomatic carotid artery stenosis transient ischemic attack ( TIA ) stroke within last 30 day intracerebral bleeding within last 2 month acute infection exist plan pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>